Thus, untargeted screening is needed to address products with potential for novel contents and emissions
(7) The ACO has in place an adequate repayment mechanism in accordance with 425.204(f) that can be used to recoup outstanding prepaid shared savings
CMS notes that, if CMS were to finalize this alternative approach, CMS would be unable to use this approach to calculate the benchmark period manufacturer price in the case of a new NDC-9 of an existing Part D rebatable drug with base date AMP that does not overlap with the time period described in proposed 428.202(c)(1) or (2)
Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (79 FR 29844) (hereinafter referred to as the Parts C and D Overpayment Final Rule), which provided, among other things, that an MAO or PDP sponsor has identified an overpayment when the MAO or PDP sponsor has determined, or should have determined through the exercise of reasonable diligence, that the MAO or PDP sponsor has received an overpayment
Wide cuts are long cut, just a little wider
Under our analysis, our proposed scoring methodology would not negatively impact MIPS eligible clinicians whose average costs for a specific cost measure are around the median
